A new publication on plecanatide appeared on October 26, 2026. The paper, titled "Gut relief revisited: plecanatide in chronic idiopathic constipation and irritable bowel syndrome with constipation - a systematic review and meta-analysis with GRADE assessment," was published in BMC Gastroenterology.
The publication is described as a systematic review and meta-analysis, incorporating a GRADE assessment framework. It focuses on plecanatide use in two conditions: chronic idiopathic constipation and irritable bowel syndrome with constipation.
No specific findings, outcome data, or conclusions from the review have been detailed beyond the publication itself appearing in the journal. This brief reports only the existence and bibliographic details of the publication as listed.
Readers interested in plecanatide's approved uses and background can consult the compound overview for further context.